Related Experiment Video
Updated: Jan 21, 2026
09:12
Nanoparticle-mediated siRNA Gene-silencing in Adult Zebrafish Heart
Published on: July 29, 2018
8.6K
Ligand Conjugated Multimeric siRNAs Enable Enhanced Uptake and Multiplexed Gene Silencing
Jonathan M Brown1, James E Dahlman1,2, Kristin K Neuman1
1MPEG LA, Chevy Chase, Maryland.
Nucleic Acid Therapeutics
|August 9, 2019
Summary
Chemically linked small interfering RNA (siRNA) multimers enhance drug delivery efficiency. This novel approach enables multigene silencing in vivo using a single ligand, improving targeted therapies.
Area of Science:
- Oligonucleotide chemistry
- RNA interference therapeutics
- Drug delivery systems
Background:
- N-acetylgalactosamine (GalNAc)-conjugated small interfering RNAs (siRNAs) are effective therapeutics.
- Current targeted therapies face limitations due to inefficient siRNA delivery by non-GalNAc ligands.
- Strategies to improve siRNA conjugate potency often focus on ligand efficacy or siRNA stability.
Purpose of the Study:
- To develop a novel system for delivering multiple siRNAs per ligand to enhance therapeutic efficacy.
- To investigate the potential of chemically linked siRNA multimers for improved intracellular delivery.
- To demonstrate simultaneous multigene silencing in vivo using ligand-directed multimeric siRNA.
Main Methods:
- Chemically synthesized and characterized siRNA multimers under neutral aqueous conditions.
- Conjugated siRNA multimers to N-acetylgalactosamine (GalNAc) ligands.
- Evaluated the in vivo activity of GalNAc-siRNA multimer conjugates in animal models.
Main Results:
- siRNA multimers were stably formed and delivered effectively in vivo via GalNAc ligands.
- Conjugates with multiple copies of the same siRNA demonstrated enhanced activity per ligand unit.
- Simultaneous silencing of multiple genes was achieved in vivo using a single GalNAc ligand directing different siRNAs.
Conclusions:
- siRNA multimers offer a practical and powerful method to enhance oligonucleotide conjugate delivery.
- This approach overcomes limitations of current siRNA delivery systems.
- Multimeric siRNA technology opens new avenues for developing advanced targeted therapies and multigene silencing strategies.
More Related Videos
11:53Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers
Published on: July 21, 2017
7.7K
13:40Live Cell Calcium Imaging Combined with siRNA Mediated Gene Silencing Identifies Ca2+ Leak Channels in the ER Membrane and their Regulatory Mechanisms
Published on: July 7, 2011
18.6K
Related Concept Videos
02:30siRNA - Small Interfering RNAs
18.4K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.4K
02:40Ligand Binding Sites
14.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.9K
02:50Conjugated Proteins
27.5K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
27.5K
02:50Conjugated Proteins
3.1K
3.1K
02:51Metal-Ligand Bonds
24.0K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
24.0K
00:49Ligand Binding and Linkage
5.5K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.5K